摘要
目的:舒督通络方治疗脾肾阳虚型强直性脊柱炎(ankylosing spondylitis,AS)的临床疗效。方法:将80例AS患者采用随机数字表法分为对照组与治疗组。对照组给予甲氨蝶呤(Methotrexatc,MTX),治疗组予以舒督通络方,连续服用3个月。试验终点时间为第3个月。在治疗前后测定患者的Bath AS功能指数(BASFI)、Bath AS活动指数(BASDAI)、疼痛视觉模拟量表(visual analog scale,VAS)评分、晨僵时间、脊柱活动度、Harris评分、ESR、CRP指标等。结果:治疗后治疗组患者BASFI、BASDAI指数、VAS评分、晨僵时间、脊柱活动度、Harris评分、ESR、CRP指标较对照组改善较明显。结论:舒督通络方可以改善患者的临床症状、疼痛程度、晨僵时间,有效治疗脾肾阳虚型强直性脊柱炎。
ObjectiveTo observe the clinical effect of Shudu Tongluo formula treating ankylosing spondylitis(AS) of yang defciency of spleen and kidney type . Methods:There were 80 with AS patients randomly divided into the control group and treatment group. The control group was given methotrexatc(MTX), and the treatment group was given Shudu Tongluo formula . The treatment lasted for 3 months. After the third month,the experiment was completed. Before and after treatment, determination of Bath AS functional index (BASFI) , Bath AS disease activity index (BASDAI), visual analog scale (VAS) score, the duration of morning stiffness, spinal mobility, Hassis scale, ESR、CRP index, and so on. Results:After treatment, BASFI, BASDAI, VAS score, the duration of morning stifness, spine activity, Harris score, ESR and CRP index were better than those in the control group. Conclusion: Shudu Tongluo formula can improve the clinical symptoms, pain degree and the duration of morning stifness, and efectively treat ankylosing spondylitis of yang defciency of spleen and kidney type .
出处
《中医临床研究》
2018年第30期99-102,共4页
Clinical Journal Of Chinese Medicine
关键词
强直性脊柱炎
脾肾阳虚
舒督通络
疗效观察
Ankylosing spondylitis
Yang defciency of spleen and kidney type
Shudu Tongluo
Efect observation